Advanced search
Enter a research title, an expert name, a programme code such as ADSTEM, or a patent number such as 10-1172638. Results appear as cards with source links you can check yourself.
4 records for “PDSTEM”
Each record states the study stage, institution and source link.
preclinical · 2024
EHL BIO (Korea)
The hospital's affiliated research centre states the programme is at non-clinical stage, so there are no efficacy or safety data in people with Parkinson's disease, and it is not approved treatment.
EHL BIO (research page)phase1-2 · 2025
Specialised research centres in Japan and the United States
Reports procedural safety and graft survival in small numbers of participants; motor outcomes require long-term follow-up.
ClinicalTrials.govpreclinical · 2024
EHL BIO (Korea)
The hospital's affiliated research centre states animal testing for patent application, listing neuropathic pain, cartilage regeneration, wound healing, hypertension, Alzheimer's disease, retinopathy, Parkinson's disease and diabetes as indications under study.
EHL BIO (other R&D page)Published profiles contain only details checkable against public sources.
EHL BIO
Stem cell therapeutics research and development team
ADSTEM (atopic dermatitis), KDSTEM (chronic kidney disease), RASTEM (rheumatoid arthritis), PDSTEM (Parkinson's disease) and adipose-derived exosome programmes
EHL BIO — Stem cell treatmentAn EHL doctor or scientist? Submit your real biography and licence for the register.
Submit expert profile